USP Compounding Chapters: Understanding the Latest Revisions

Chair, USP Compounding Expert Committee; Owner and Compounding Pharmacy Consultant, Compounding Consultants, LLC

Brenda Jensen, CPhT, CNMT, MBA, is the current chair of the USP Compounding Expert Committee and previously was a member of the 2015-2020 Compounding Expert Committee. She also participates on the Radiopharmaceutical Standards Expert Panel. Jensen is an independent consultant and owner of Compounding Consultants, LLC. She helps facilities improve compounding quality and safety by providing gap analyses, on-site training, and customized standard operating procedures. Her previous experience includes sterile and nonsterile compounding in hospital, clinic, and community pharmacy settings. Her sterile compounding experience includes oncology, nuclear, and high-risk level compounding. Jensen is a member of multiple pharmacy organizations, president of the American College of Veterinary Pharmacists, and a member of the American Pharmacists Association (APhA) House of Delegates.

Member, USP Compounding Expert Committee; Chief Scientific Officer, Professional Compounding Centers of America

Gus Bassani, PharmD, currently serves as chief scientific officer for PCCA, a Houston-based supplier of active pharmaceutical ingredients and excipients and formulation and drug information consulting to pharmacies, health care institutions, and outsourcing facilities. He has been with PCCA since 2002. Before that, he was a formulation pharmacist in the product development lab of a veterinary pharmaceutical company. Dr Bassani has worked in multiple pharmacy practice settings in Alaska, Iowa, and Kansas, and has taught extemporaneous compounding principles to pharmacy students in Drake University’s Pharmaceutics Laboratory course. He received his doctor of pharmacy degree from Drake University College of Pharmacy and Health Sciences. He is a member of the 2020-2025 USP Compounding Expert Committee and chairs the <795> Subcommittee. Previously, he was a member of the 2010-2015 and 2015-2020 USP Compounding Expert Committees. Gus served on the 2012-2014 Drake University College of Pharmacy and Health Sciences National Advisory Council and is a member of the APhA, the Alliance for Pharmacy Compounding, the American Association of Pharmaceutical Scientists, and the National Community Pharmacists Association.

Member, USP Compounding Expert Committee; President and Chief Executive Officer, National Home Infusion Association

Connie Sullivan, BS Pharm, is the president and chief executive officer of the National Home Infusion Association (NHIA). Sullivan has over 25 years of home infusion industry leadership, management, and clinical practice experience. She is responsible for NHIA’s legislative and regulatory advocacy initiatives and developing resources that support the infusion industry to foster innovation and promote the delivery of high-quality patient care. Sullivan also oversees the National Home Infusion Foundation, a not-for-profit subsidiary of the association devoted to research, leadership development, and education programs. She is a member of the 2020-2025 USP Compounding Expert Committee and chairs the <797> Subcommittee. Before joining NHIA, Sullivan served for 15 years as the national director of infusion for a national home health and skilled nursing provider. She earned her bachelor’s degree in pharmacy from The Ohio State University College of Pharmacy in 1994.